Merck says research shows its Covid-19 pill works against variants | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 18, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 18, 2025
Merck says research shows its Covid-19 pill works against variants

Coronavirus chronicle

Reuters
30 September, 2021, 11:30 am
Last modified: 30 September, 2021, 11:32 am

Related News

  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • 7 new Covid-19 cases reported in 24hrs
  • Covid hospitals in Chattogram face ICU, testing kit crisis amid rising infections
  • DGHS issues 11-point directive to prevent spread of Covid-19 in Bangladesh
  • Tourist surge raises fresh Covid-19 concerns in Rangamati

Merck says research shows its Covid-19 pill works against variants

Data shows that the drug is most effective when given early in the course of infection

Reuters
30 September, 2021, 11:30 am
Last modified: 30 September, 2021, 11:32 am
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. Photo: Reuters
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. Photo: Reuters

Laboratory studies show that Merck & Co's experimental oral Covid-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday.

Since molnupiravir does not target the spike protein of the virus - the target of all current Covid-19 vaccines - which defines the differences between the variants, the drug should be equally effective as the virus continues to evolve, said Jay Grobler, head of infectious disease and vaccines at Merck.

Molnupiravir instead targets the viral polymerase, an enzyme needed for the virus to make copies of itself. It is designed to work by introducing errors into the genetic code of the virus.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Data shows that the drug is most effective when given early in the course of infection, Merck said.

The US drugmaker tested its antiviral against nasal swab samples taken from participants in early trials of the drug. Delta was not in wide circulation at the time of those trials, but molnupiravir was tested against lab samples of the variant behind the latest surge in Covid-19 hospitalizations and deaths.

Merck said earlier this year that a small, mid-stage trial found that after five days of molnupiravir treatment, none of the patients taking various doses of the drug tested positive for infectious virus, while 24% of placebo patients did have detectable levels.

Merck is currently conducting two Phase III trials of the antiviral it is developing with Ridgeback Biotherapeutics - one for treatment of Covid-19 and another as a preventive.

Merck anticipates that the Phase III treatment study will finish in early November, Grobler said.

The trial enrolled nonhospitalized Covid-19 patients who have had symptoms for no more than five days and are at risk for severe disease.

The latest analysis was presented during IDWeek, the annual meeting of infectious disease organizations, including the Infectious Diseases Society of America.

Shares of Merck were up 2.3% at $75.04 on Wednesday afternoon on the New York Stock Exchange.

Top News / World+Biz

Merck / Covid -19 / pills

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • US President Donald Trump points a finger as he departs for Canada to attend the G7 Leaders' Summit, from Joint Base Andrews in Maryland, US, June 15, 2025. Photo: REUTERS/Kevin Lamarque
    Trump demands Iran's 'unconditional surrender' as Israel-Iran air war rages on
  • Infographics: Duniya Jahan/TBS
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • Iran's supreme leader Ali Khamenei and US president-elect Donald Trump. Photo: Collected
    'Not going to kill Khamenei, at least for now', says Trump, claiming US knows Iran's supreme leader's location

MOST VIEWED

  • Former Bangladesh High Commissioner to the UK Saida Muna Tasneem. Photo: Collected
    ACC launches inquiry against ex-Bangladesh envoy Saida Muna, husband over laundering Tk2,000cr
  • Infograph: TBS
    Ship congestion at Ctg port lingers as berthing time rises
  • A view of Iranian missiles across the sky as seen by Biman pilot Enam Talukder. Photo: Enam Talukder
    Biman pilot witnessed Iran's missiles flying towards Israel
  • Power Division wants Tk56,000cr PDB loans turned into subsidy
    Power Division wants Tk56,000cr PDB loans turned into subsidy
  • BNP leader Ishraque Hossain held a view-exchange meeting with waste management officials and Dhaka South City Corporation staff inside Nagar Bhaban on 16 June 2025. Photos: Hasan Mehedi
    Ishraque holds Nagar Bhaban meeting as 'Dhaka South mayor', says it’s people’s demand
  • Bangladesh gains bigger share in US apparel market as China loses ground, sees 29% export growth in Jan-Apr
    Bangladesh gains bigger share in US apparel market as China loses ground, sees 29% export growth in Jan-Apr

Related News

  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • 7 new Covid-19 cases reported in 24hrs
  • Covid hospitals in Chattogram face ICU, testing kit crisis amid rising infections
  • DGHS issues 11-point directive to prevent spread of Covid-19 in Bangladesh
  • Tourist surge raises fresh Covid-19 concerns in Rangamati

Features

The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

10h | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

1d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

2d | Panorama
Photos: Collected

Kurtis that make a great office wear

4d | Mode

More Videos from TBS

What's behind the animosity between former allies Iran and Israel?

What's behind the animosity between former allies Iran and Israel?

6h | Others
21 Muslim countries condemn Israeli attack on Iran

21 Muslim countries condemn Israeli attack on Iran

7h | TBS World
News of The Day, 17 JUNE 2025

News of The Day, 17 JUNE 2025

9h | TBS News of the day
Rising default loans threaten jobs, growth, trade

Rising default loans threaten jobs, growth, trade

11h | TBS Insight
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net